The survival time of liver metastasis in advanced stage of lung cancer is closely related to the physical quality of the patient and the severity of the disease, so the exact time cannot be predicted, so it is recommended to follow the doctor’s instruction to standardize the treatment.
When liver metastasis occurs in the advanced stage of lung cancer, radiotherapy and targeted therapy can be chosen to improve the prognosis of the disease, inhibit the spread of tumor, reduce the tumor foci, improve the quality of life and prolong the survival time of patients.
The chemotherapy drugs that patients can choose include cyclophosphamide, cisplatin, paclitaxel, etc. The targeted drugs include erlotinib, gefitinib, etc. As there is no absolute most effective drug, it is not the most effective drug. Since there is no absolute most effective drug, it needs to be standardized under the guidance of the doctor. Adverse reactions are recommended to consult a doctor, and drug allergy is prohibited.
Patients are advised to relax and adhere to the treatment, which will help prolong the survival time.